Please login to the form below
statins
This page shows the latest statins news and features for those working in and with pharma, biotech and healthcare.
CHMP recommends EU approval for Amarin’s cardiovascular risk reduction drug
The drug is recommended for use in adult patients who are already receiving statin treatment. ... The committee has recommended use of the drug in adult patients already receiving statin treatment, and who have elevated triglycerides.
Latest news
-
AZ divests European rights for cholesterol med Crestor to Grünenthal
Crestor is a statin medication approved for the treatment of dyslipidaemia and hypercholesterolaemia, conditions that are characterised by the presence of high cholesterol levels in the blood.
-
Novartis scores CHMP backing for cholesterol drug Leqvio
The positive opinion is based on results from Novartis’ ORION clinical research programme, including phase 3 trials which involved over 3, 600 patients on a maximum statin dose. ... levels that have not been brought down by a maximum statin dose.
-
Amarin shares tumble following Vascepa patent loss
It became the first US Food and Drug Administration (FDA)-approved drug to reduce cardiovascular risk in patients with elevated triglyceride levels as an add-on to maximally tolerated statin therapy.
-
Esperion gets FDA thumbs up for cholesterol drug Nexletol
The US regulator has cleared Nexletol (bempedoic acid) as an add-on to diet and maximum-dose statin therapy for patients with atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH), ... C-reactive protein”
-
Novartis plans inclisiran trial in the UK
statins alone.
More from news
Approximately 11 fully matching, plus 219 partially matching documents found.
Latest Intelligence
-
Sourcing R&D innovation: why pharma companies need to evolve their business models
Examples of this approach include developing statins for the treatment of dyslipidemia, angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) for hypertension, and glucagon-like peptide 1
-
Treatment and prevention of cardiovascular disease
type 2 diabetes treatments, LDL cholesterol management with statins, blood pressure- lowering medications, antiplatelet agents and other treatments. ... These findings represented a potentially notable advance in cardiovascular disease prevention, after
-
Cortellis Drugs to Watch in 2020 report
It will face competition mainly from generic statins and PCSK9 inhibitor monoclonal antibodies.
-
A roadmap to the successful treatment of Alzheimer’s disease
This would create a similar situation to cardiovascular disease where we use cholesterol as a biomarker and give statins in a preventative mode.
-
Holding on to hope for Alzheimer’s advances
In terms of BACE, Prof Roberts said: “Although the drug companies would love to have a drug that you could take like statins against hypercholesterolaemia, to give long-term protection against
More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.
Latest from PMHub
-
World Heart Day 2020: It's time to make our clinical trials more inclusive
This is a trend seen across various types of cardiovascular disease treatments, including statins, beta-blockers and ACE inhibitors.
-
Fake News is Bad for your Health
Millions of people take statins to reduce their risk of dying prematurely, but how would they feel if they were told that 67 people need to be treated to reduce one
-
Digital Marketing is no Substitute for Sound Strategic Marketing
To build equivalent marketing capabilities, pharmaceutical companies invested in training, processes and teams to create highly effective marketing machines, as illustrated by the ‘statin’ wars of the late 90’s/early
-
How do you define a biotech company?
benefit (eg: statins, PD-1s or TNFs).
-
The changing face of medical communications over the past 15 years
We used to work on products such as calcium-channel blockers, statins and ACE inhibitors.
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Content Editor - Biotechnology
-
Salary TBC
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- GSK discontinues two feladilimab trials in head and neck cancer
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- FDA approves new self-injection administration for Xolair
- Lilly asks to revoke emergency authorisation for bamlanivimab monotherapy in the US
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Alexion and NICE agree confidential discount for Ultomiris use on the NHS
- Novartis’ MS therapy Kesimpta reduces risk of disability progression regardless of relapses
- Merck & Co halts development of potential COVID-19 drug MK-7110
- Virtually, the same: Is it time to rethink congress strategy?
PMHub
OPEN Health
OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...
Latest intelligence
- InSite Events™ National Pharma Meeting: A Customer Story
- How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
- Fear or encouragement, which is best to drive behaviour change?
- The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
- The unheard, unseen, and uncorrected effects of COVID-19
- The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...
Quick links
Infographics
